Effect of a Novel Pancreatic Stent Design on Short-Term Pancreatic Injury in a Canine Model

Background and Study Aims: Attempts to address the problem of injury to the pancreas by indwelling pancreatic stents are limited by our lack of knowledge of the pathogenesis of stent-induced injury and its relationship to stent morphology and the duration of stenting. The aim of our study was to evaluate pancreatic injury induced by 1 week of stenting with a 5F indwelling pancreatic stent of novel design, the “wing stent.”
Methods: Pancreatic stents (5F) were placed surgically in eight dogs; wing stents (WS-5F) were used in four dogs and conventional stents (CS-5F) in another four. Two dogs underwent duodenotomy without stent placement (controls). The pancreas was harvested for microscopy at 1 week. A pathologist who was unaware of the source of the specimens graded the pancreatic injury.
Results: Although pancreatic injury was observed in both the CS-5F and WS-5F groups after 1 week of indwelling pancreatic stenting, it was considerably less severe in the WS-5F group compared with the CS-5F group (1.01 ± 0.10 vs. 1.63 ± 0.14, P < 0.01). All components of pancreatic injury were affected, with the most dramatic differences noted in inflammation, fibrosis, and edema. The differences were most marked in the stented segment (P < 0.001) and in the upstream segment of the pancreas (P < 0.05).
Conclusions: Indwelling conventional pancreatic stents can cause significant pancreatic injury even when left in place for only 1 week. A wing design can significantly ameliorate stent-induced changes.

References

• 1 Sherman S, Lehman G A. Endoscopic therapy of pancreatic disease.  Gastroenterologist. 1997;  5 262-277
• 2 Kozarek R A. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis.  Gastrointest Endosc. 1990;  36 93-95
• 3 Smith M T, Sherman S, Ikenberry S O. et al . Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy.  Gastrointest Endosc. 1996;  44 268-275
• 4 Sherman S, Hawes R H, Savides T J. et al . Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP.  Gastrointest Endosc. 1996;  44 276-282
• 5 Alvarez C, Robert M, Sherman S, Reber H A. Histologic changes after stenting of the pancreatic duct.  Arch Surg. 1994;  129 765-768
• 6 Sherman S, Alvarez C, Robert M. et al . Polyethylene pancreatic duct stent-induced changes in the normal dog pancreas.  Gastrointest Endosc. 1993;  39 658-664
• 7 Hashimoto T, Yamada T, Yokoi T. et al . Apoptosis of acinar cells is involved in chronic pancreatitis in Wbn/Kob rats: role of glucocorticoids.  Pancreas. 2000;  21 296-304
• 8 Freeman M L, Guda N M. Prevention of post-ERCP pancreatitis: a comprehensive review.  Gastrointest Endosc. 2004;  59 845-864
• 9 Rashdan A, Fogel E L, McHenry L Jr. et al . Improved stent characteristics for prophylaxis of post-ERCP pancreatitis.  Clin Gastroenterol Hepatol. 2004;  2 322-329
• 10 Raijman I. Biliary and pancreatic stents.  Gastrointest Endosc Clin N Am. 2003;  13 561-592